- therapies.
Sunovion was
founded as
Sepracor, Inc. in 1984 by
Timothy J. Barberich,
Steve Matson, and Bob Bratzler.
Sepracor completed its
initial public offering...
- benzodiazepine-like
drugs for a few w****s. A
study funded and
carried out by
Sepracor, the
manufacturer of eszopiclone,
found no
signs of
tolerance or dependence...
-
originally synthesized in 1993 by M****achusetts-based
biotechnology company Sepracor,
which then sold the
development rights to
Hoechst Marion Roussel (now...
- who had
worked at the
Searle division of
Monsanto and then had gone to
Sepracor.
Currie directed the
efforts that led to the
discovery of linaclotide,...
- (1990– )
Stryker (1941– )
Sumitomo (2005– ) Sun (1983– )
Sunovion (formerly
Sepracor) (1984– )
Sutro (2003– )
Swedish Orphan Biovitrum (2001– )
Synthon (1991–...
- Chichester:
Ellis Horwwod. pp. 31–68. "European
Medicines Agency - -
Sepracor Pharmaceuticals Ltd
withdraws its
marketing authorisation application for...
- pour la
Propulsion par Réaction,
French rocket-engine
manufacturer Sepracor Sepracor, Inc. (
former NASDAQ: SEPR ),
pharmaceutical company United Socialist...
-
Barton in
Taunton (factory and headquarters) Saint-Gobain, in
Worcester Sepracor, Inc., in
Marlborough (headquarters) Staples, Inc., in
Framingham (headquarters)...
- stereoisomers, only one of
which is active. In 2005, the
pharmaceutical company Sepracor of Marlborough, M****achusetts,
began marketing the
active stereoisomer...
- in
North America, then-Sumitomo
Dainippon Pharma acquired NASDAQ-traded
Sepracor for $2.6B in 2010,
renaming its new stand-alone
subsidiary Sunovion. Under...
